Sage Journals: Discover world-class research

Free access

Research article

First published 2006-8

Combinatorial Ribavirin and Interferon Alfacon-1 Therapy of Acute Arenaviral Disease in Hamsters

Brian B Gowen, Donald F Smee, Min-Hui Wong [...]

Antiviral Chemistry and Chemotherapy

Free access

Research article

First published 2010-4

Induction of Interferon-γ-Inducible Protein 10 by SARS-CoV Infection,Interferon Alfacon 1 and Interferon Inducer in Human Bronchial Epithelial Calu-3 Cells and BALB/c Mice

Yohichi Kumaki, Craig W Day, Kevin W Bailey [...]

Antiviral Chemistry and Chemotherapy

Free access

Research article

First published 2005-2

Dynamic Changes in Clinical Features and Cytokine/Chemokine Responses in Sars Patients Treated with Interferon Alfacon-1 plus Corticosteroids

Sarah E Ward, Mona R Loutfy, Lawrence M Blatt [...]

Antiviral Therapy

Free access

Research article

First published 2000-10

Spectrum of Virus Inhibition by Consensus Interferon YM643

Shuhei Yasuda, John H Huffman, Donald F Smee [...]

Antiviral Chemistry and Chemotherapy

Retricted access

Research article

First published 2005-10

Global Transcriptional Profiling Demonstrates the Combination of Type I and Type II Interferon Enhances Antiviral and Immune Responses at Clinically Relevant Doses

Hua Tan, Jena Derrick, Jin Hong [...]

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 2016-03

Small Molecule Agonists for the Type I Interferon Receptor: An In Silico Approach

Lianhu Wei, Angelica M. Bello, Beata Majchrzak-Kita [...]

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 2009-05

Reporting On Adverse Clinical Events

Clin-Alert

Search results

Combinatorial Ribavirin and Interferon Alfacon-1 Therapy of Acute Arenaviral Disease in Hamsters

Induction of Interferon-γ-Inducible Protein 10 by SARS-CoV Infection,Interferon Alfacon 1 and Interferon Inducer in Human Bronchial Epithelial Calu-3 Cells and BALB/c Mice

Dynamic Changes in Clinical Features and Cytokine/Chemokine Responses in Sars Patients Treated with Interferon Alfacon-1 plus Corticosteroids

Spectrum of Virus Inhibition by Consensus Interferon YM643

Global Transcriptional Profiling Demonstrates the Combination of Type I and Type II Interferon Enhances Antiviral and Immune Responses at Clinically Relevant Doses

Small Molecule Agonists for the Type I Interferon Receptor: An In Silico Approach

Reporting On Adverse Clinical Events